The trademark REMOXIN was filed by Novartis AG, a corporation established under the laws of the Swiss Confederation (the "Applicant"). The application was published for oppositions on April 8, 2021, and received one opposition filed on July 5, 2021 by SC TIS FARMACEUTIC SA on Likelihood of confusion. the opponent was represented by Borlan, Radu and proceedings were handled in English, and the oppositon was dismissed by the Euorpean Union Intellectual Property Office with decision issued July 5, 2021
The application was filed in English, and English was also language of all opposition proceedings (French was selected as the second language).
Change of name and address of the trademark registration was recorded on May 4, 2022. Change of name and address of the trademark registration was recorded on May 16, 2022.